Research programme: junctional adhesion molecule A inhibitors - Pierre Fabre

Alternative Names: 6F4; Anti-JAM-A protein antibodies - Pierre Fabre Centre d’Immunologie; Mab 6F4; Project F50073 - Pierre Fabre Centre d’Immunologie

Latest Information Update: 01 Sep 2016

Price : ^*

* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

Originator Pierre Fabre Centre d'Immunologie
Class Monoclonal antibodies
Mechanism of Action Immunomodulators; Protein inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes

Highest Development Phases

Preclinical Cancer

Most Recent Events

30 Aug 2016 Preclinical trials in Cancer in France (Intraperitoneal) before August 2016 (Pierre Fabre Centre d’Immunologie pipeline, August 2016)

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login with a username/password associated to an account with a valid subscription
Contact your organization’s admin about adding this content to your AdisInsight subscription
Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.